Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide
- PMID: 15501516
- PMCID: PMC7115412
- DOI: 10.1016/j.peptides.2004.06.018
Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide
Abstract
The cleavage mechanism of severe acute respiratory syndrome (SARS) coronavirus main proteinase (M(pro) or 3CL(pro)) for the octapeptide AVLQSGFR is studied using molecular mechanics (MM) and quantum mechanics (QM). The catalytic dyad His-41 and Cys-145 in the active pocket between domain I and II seem to polarize the pi-electron density of the peptide bond between Gln and Ser in the octapeptide, leading to an increase of positive charge on C(CO) of Gln and negative charge on N(NH) of Ser. The possibility of enhancing the chemical bond between Gln and Ser based on the "distorted key" theory [Anal. Biochem. 233 (1996) 1] is examined. The scissile peptide bond between Gln and Ser is found to be solidified through "hybrid peptide bond" by changing the carbonyl group CO of Gln to CH(2) or CF(2). This leads to a break of the pi-bond system for the peptide bond, making the octapeptide (AVLQSGFR) a "distorted key" and a potential starting system for the design of anti SARS drugs.
Figures





Similar articles
-
Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase.Anal Biochem. 2005 Feb 15;337(2):262-70. doi: 10.1016/j.ab.2004.10.003. Anal Biochem. 2005. PMID: 15691506 Free PMC article.
-
A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.Acta Pharmacol Sin. 2003 Jun;24(6):497-504. Acta Pharmacol Sin. 2003. PMID: 12791174
-
QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).J Mol Graph Model. 2008 Oct;27(3):275-85. doi: 10.1016/j.jmgm.2008.05.002. Epub 2008 May 9. J Mol Graph Model. 2008. PMID: 18567519 Free PMC article.
-
Activation and maturation of SARS-CoV main protease.Protein Cell. 2011 Apr;2(4):282-90. doi: 10.1007/s13238-011-1034-1. Epub 2011 Apr 28. Protein Cell. 2011. PMID: 21533772 Free PMC article. Review.
-
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920. Molecules. 2020. PMID: 32867349 Free PMC article. Review.
Cited by
-
Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX.Sci Rep. 2023 Jul 21;13(1):11783. doi: 10.1038/s41598-023-39071-z. Sci Rep. 2023. PMID: 37479788 Free PMC article.
-
Quinazolinone-Peptido-Nitrophenyl-Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease.Viruses. 2023 Jan 19;15(2):287. doi: 10.3390/v15020287. Viruses. 2023. PMID: 36851501 Free PMC article.
-
In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry.Turk J Biol. 2021 Aug 30;45(4):442-458. doi: 10.3906/biy-2012-52. eCollection 2021. Turk J Biol. 2021. PMID: 34803446 Free PMC article.
-
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review.Int J Mol Sci. 2021 Oct 14;22(20):11069. doi: 10.3390/ijms222011069. Int J Mol Sci. 2021. PMID: 34681727 Free PMC article.
-
Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold.Front Pharmacol. 2021 May 13;12:666664. doi: 10.3389/fphar.2021.666664. eCollection 2021. Front Pharmacol. 2021. PMID: 34079462 Free PMC article. Review.
References
-
- Althaus I.W., Chou J.J., Gonzales A.J., Diebel M.R., Chou K.C., Kezdy F.J., et al. Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E. Biochemistry. 1993;32:6548–6554. - PubMed
-
- Althaus I.W., Chou J.J., Gonzales A.J., Diebel M.R., Chou K.C., Kezdy F.J., et al. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. J. Biol. Chem. 1993;268:6119–6124. - PubMed
-
- Althaus I.W., Chou J.J., Gonzales A.J., Diebel M.R., Chou K.C., Kezdy F.J., et al. Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor. Experientia. 1994;50:23–28. - PubMed
-
- Althaus I.W., Chou J.J., Gonzales A.J., Diebel M.R., Chou K.C., Kezdy F.J., et al. Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-90152E. Biochem. Pharmacol. 1994;47:2017–2028. - PubMed
-
- Althaus I.W., Chou K.C., Franks K.M., Diebel M.R., Kezdy F.J., Romero D.L., et al. The benzylthio-pyrididine U-31355 is a potent inhibitor of HIV-1 reverse transcriptase. Biochem. Pharmacol. 1996;51:743–750. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous